Michael Roche

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo

Paul R. Gorry, Dale A. McPhee, Erin E. Verity et al. · Retrovirology · 2007 · 101 citations · Full text

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy

Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin et al. · Science Translational Medicine · 2022 · 97 citations · Full text

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

Jasminka Sterjovski, Melissa J. Churchill, Anne Ellett et al. · Retrovirology · 2007 · 91 citations · Full text

HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

Michael Roche, Martin R. Jakobsen, Jasminka Sterjovski et al. · Journal of Virology · 2011 · 80 citations · Full text

Inflammation, Hiv-1 Escape, Mvc Results +15

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Michael Roche, Hamid Salimi, Renee C. Duncan et al. · Retrovirology · 2013 · 68 citations · Full text